Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001753926-25-001403
Filing Date
2025-08-28
Accepted
2025-08-28 16:06:19
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 g084932_s3.htm S-3 649917
2 EXHIBIT 5.1 g084932_ex5-1.htm EX-5.1 12952
3 EXHIBIT 23.1 g084932_ex23-1.htm EX-23.1 3265
4 EXHIBIT 107 g084932_ex107.htm   iXBRL EX-FILING FEES 34977
5 GRAPHIC img001_v1.jpg GRAPHIC 37322
6 GRAPHIC img002_v1.jpg GRAPHIC 38163
7 GRAPHIC img001_v4.jpg GRAPHIC 12633
  Complete submission text file 0001753926-25-001403.txt   954286

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT g084932_ex107_htm.xml XML 8878
Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289916 | Film No.: 251273406
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)